Health Care & Life Sciences » Pharmaceuticals | Chongqing Lummy Pharmaceutical Co. Ltd.

Chongqing Lummy Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
63,152.40
11,264.80
20,397.40
1,253.20
46,063.30
91,134.80
Depreciation, Depletion & Amortization
52,946.30
81,875.20
108,633.80
113,947.50
112,834.80
108,081.50
Other Funds
340,101.00
9,353.40
609,210.70
41,389.90
72,920.60
98,214.40
Funds from Operations
155,182.20
139,760.70
205,540.00
195,658.40
197,636.00
293,130.70
Changes in Working Capital
74,679.30
185,700.40
230,947.60
71,802.80
133,047.70
22,677
Net Operating Cash Flow
80,502.90
45,939.70
25,407.70
123,855.70
64,588.30
270,453.70
Capital Expenditures
355,405.00
153,911.80
55,187.10
76,975.50
21,043.80
Sale of Fixed Assets & Businesses
100,014.80
3,394.60
2,706.60
7,826.30
8,970.20
Purchase/Sale of Investments
87,295.00
85,900.00
76,042.40
124,438.00
107,108.20
Net Investing Cash Flow
335,778.70
237,025.60
140,031.90
180,450.70
118,796.90
Cash Dividends Paid - Total
-
20,179.40
20,179.40
22,562.30
40,612.10
Issuance/Reduction of Debt, Net
174,700.00
51,146.00
244,426.50
497,233.80
168,766.40
Net Financing Cash Flow
514,801.00
21,613.30
833,457.90
562,169.10
55,233.80
Net Change in Cash
259,525.20
261,558.70
668,626.30
618,429.70
181.20
Free Cash Flow
274,902.10
199,851.50
80,594.80
46,880.20
43,544.50
Deferred Taxes & Investment Tax Credit
784.50
12,176.20
7,297.40
18,851.10
14,230.80
4,300
Other Sources
19,276.00
2,857.50
7,598.30
15,136.50
4,241.20
Change in Capital Stock
-
-
-
983.30
-
Exchange Rate Effect
-
206.80
608.00
334.40
843.90
Other Uses
12,369.50
3,466.00
19,107.30
2,000.00
3,856.30

About Chongqing Lummy Pharmaceutical Co.

View Profile
Address
15th Floor, Tower B
Chongqing Chongqing 401123
China
Employees -
Website http://www.cqlummy.com
Updated 07/08/2019
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical. Its products include tumor drugs, antibacterial drugs, antifungal drugs, antiviral agent, digestive system agents, immune system agents, blood system agents, cardiovascular system agents, nervous system agents, electrolyte and acid-base balance and nutritional, liver disease auxiliary drugs, endocrinology system drugs, Chinese patent drugs, base large infusion, American ginseng and active pharmaceutical ingredients. The company was founded on September 6, 1999 and is headquartered in Chongqing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.